Lysophosphatidic Acid as a Potential Biomarker for Ovarian and Other Gynecologic Cancers
Author(s) -
YanMing Xu
Publication year - 1998
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.280.8.719
Subject(s) - lysophosphatidic acid , medicine , ovarian cancer , biomarker , gynecologic oncology , cancer , breast cancer , oncology , gastroenterology , stage (stratigraphy) , autotaxin , gynecologic cancer , gynecology , receptor , paleontology , biochemistry , chemistry , biology
Lysophosphatidic acid (LPA) has been shown to stimulate proliferation of ovarian cancer cells and is present in the ascitic fluid of patients with ovarian cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom